Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical). (Q34982478)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical). |
scientific article |
Statements
1 reference
Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical). (English)
1 reference
Stephan Rossner
1 reference
Peter Kopelman
1 reference
Gerrit de H Groot
1 reference
Aila Rissanen
1 reference
Soren Toubro
1 reference
Richard Palmer
1 reference
Rob Hallam
1 reference
Andrew Bryson
1 reference
Roger I Hickling
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference